AURORA (PET MPI)

A Phase 3, Open-Label, Multicentre Study of Flurpiridaz Injection for Positron Emission Tomography (PET) Imaging for Assessment of Myocardial Perfusion in Patients Referred for Invasive Coronary Angiography Because of Suspected Coronary Artery Disease

Stage
klaar
Medicine
flurpiridaz, injection
Population
ASCVD
Phase
III
First Patient In
1 May 2019
Last Patient In
31 March 2022
Last Patient Last Visit
12 April 2022

National Lead

dr. J. Schaap

Cardioloog

Office Contact

S. Jansen

Studiemanager

The page has expired.